| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.16e-09 | 188 | 40 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 3.22e-05 | 31 | 40 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | structural molecule activity | 5.28e-05 | 891 | 40 | 9 | GO:0005198 | |
| GeneOntologyMolecularFunction | integrin binding | 4.07e-04 | 175 | 40 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.61e-04 | 16 | 40 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 6.55e-04 | 19 | 40 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 6.56e-04 | 85 | 40 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 8.02e-04 | 21 | 40 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | Notch binding | 1.33e-03 | 27 | 40 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.33e-03 | 27 | 40 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.98e-03 | 268 | 40 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.53e-03 | 749 | 40 | 6 | GO:0005509 | |
| GeneOntologyMolecularFunction | growth factor binding | 3.74e-03 | 156 | 40 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 6.60e-03 | 599 | 40 | 5 | GO:0050839 | |
| GeneOntologyMolecularFunction | heparin binding | 6.66e-03 | 192 | 40 | 3 | GO:0008201 | |
| GeneOntologyBiologicalProcess | axon guidance | 6.31e-08 | 285 | 40 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 6.49e-08 | 286 | 40 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.34e-07 | 377 | 40 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.44e-07 | 378 | 40 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.55e-07 | 379 | 40 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 5.84e-07 | 84 | 40 | 5 | GO:1903053 | |
| GeneOntologyBiologicalProcess | nephron development | 1.00e-06 | 174 | 40 | 6 | GO:0072006 | |
| GeneOntologyBiologicalProcess | axon development | 2.99e-06 | 642 | 40 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | neuron projection development | LRP2 LAMA3 LGR4 LAMA5 LAMB2 LAMB3 FAT4 TNC TNXB NOTCH1 NOTCH3 OTOG | 3.55e-06 | 1285 | 40 | 12 | GO:0031175 |
| GeneOntologyBiologicalProcess | nephron epithelium development | 4.70e-06 | 128 | 40 | 5 | GO:0072009 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 5.11e-06 | 59 | 40 | 4 | GO:0085029 | |
| GeneOntologyBiologicalProcess | kidney development | 6.55e-06 | 372 | 40 | 7 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 8.33e-06 | 386 | 40 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.08e-05 | 566 | 40 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 1.16e-05 | 23 | 40 | 3 | GO:0072243 | |
| GeneOntologyBiologicalProcess | neuron development | LRP2 LAMA3 LGR4 LAMA5 LAMB2 LAMB3 FAT4 TNC TNXB NOTCH1 NOTCH3 OTOG | 1.34e-05 | 1463 | 40 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 1.48e-05 | 162 | 40 | 5 | GO:0072073 | |
| GeneOntologyBiologicalProcess | glomerulus development | 1.48e-05 | 77 | 40 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 2.14e-05 | 28 | 40 | 3 | GO:0072207 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 3.88e-05 | 198 | 40 | 5 | GO:0048754 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 5.82e-05 | 109 | 40 | 4 | GO:0034446 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 6.04e-05 | 110 | 40 | 4 | GO:0072080 | |
| GeneOntologyBiologicalProcess | renal tubule development | 7.42e-05 | 116 | 40 | 4 | GO:0061326 | |
| GeneOntologyBiologicalProcess | recognition of apoptotic cell | 7.65e-05 | 7 | 40 | 2 | GO:0043654 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 7.91e-05 | 748 | 40 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 8.92e-05 | 236 | 40 | 5 | GO:0061138 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 1.03e-04 | 47 | 40 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 1.28e-04 | 802 | 40 | 8 | GO:0048812 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 1.29e-04 | 410 | 40 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 1.36e-04 | 258 | 40 | 5 | GO:0001763 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 1.48e-04 | 819 | 40 | 8 | GO:0120039 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 1.49e-04 | 421 | 40 | 6 | GO:0060562 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.57e-04 | 826 | 40 | 8 | GO:0048858 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 1.63e-04 | 10 | 40 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 1.84e-04 | 57 | 40 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 2.00e-04 | 150 | 40 | 4 | GO:0090288 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.39e-04 | 12 | 40 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | branching involved in ureteric bud morphogenesis | 3.10e-04 | 68 | 40 | 3 | GO:0001658 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | 3.45e-04 | 927 | 40 | 8 | GO:0030155 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus development | 3.79e-04 | 15 | 40 | 2 | GO:0072224 | |
| GeneOntologyBiologicalProcess | ureteric bud morphogenesis | 3.98e-04 | 74 | 40 | 3 | GO:0060675 | |
| GeneOntologyBiologicalProcess | mesonephric tubule morphogenesis | 4.65e-04 | 78 | 40 | 3 | GO:0072171 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 5.01e-04 | 80 | 40 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 5.92e-04 | 1269 | 40 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | nephron tubule morphogenesis | 6.40e-04 | 87 | 40 | 3 | GO:0072078 | |
| GeneOntologyBiologicalProcess | nephron epithelium morphogenesis | 6.84e-04 | 89 | 40 | 3 | GO:0072088 | |
| GeneOntologyBiologicalProcess | nephron morphogenesis | 7.29e-04 | 91 | 40 | 3 | GO:0072028 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule development | 7.52e-04 | 21 | 40 | 2 | GO:0072234 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 7.53e-04 | 92 | 40 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | renal tubule morphogenesis | 7.77e-04 | 93 | 40 | 3 | GO:0061333 | |
| GeneOntologyBiologicalProcess | metanephros development | 8.26e-04 | 95 | 40 | 3 | GO:0001656 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 8.27e-04 | 22 | 40 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 8.52e-04 | 96 | 40 | 3 | GO:0060113 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 9.32e-04 | 99 | 40 | 3 | GO:0045995 | |
| GeneOntologyBiologicalProcess | transcytosis | 9.85e-04 | 24 | 40 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.07e-03 | 104 | 40 | 3 | GO:0042490 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.15e-03 | 619 | 40 | 6 | GO:0002009 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.15e-03 | 412 | 40 | 5 | GO:0090287 | |
| GeneOntologyBiologicalProcess | metanephric tubule development | 1.16e-03 | 26 | 40 | 2 | GO:0072170 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 1.17e-03 | 107 | 40 | 3 | GO:0001657 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.23e-03 | 1125 | 40 | 8 | GO:0035239 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 1.26e-03 | 110 | 40 | 3 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 1.26e-03 | 110 | 40 | 3 | GO:0072163 | |
| GeneOntologyBiologicalProcess | kidney morphogenesis | 1.30e-03 | 111 | 40 | 3 | GO:0060993 | |
| GeneOntologyBiologicalProcess | mesonephros development | 1.36e-03 | 113 | 40 | 3 | GO:0001823 | |
| GeneOntologyBiologicalProcess | response to growth factor | 1.39e-03 | 883 | 40 | 7 | GO:0070848 | |
| GeneOntologyBiologicalProcess | regeneration | 1.41e-03 | 252 | 40 | 4 | GO:0031099 | |
| GeneOntologyBiologicalProcess | muscle organ development | 1.48e-03 | 436 | 40 | 5 | GO:0007517 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 1.54e-03 | 30 | 40 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.65e-03 | 31 | 40 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 1.65e-03 | 31 | 40 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | hair follicle development | 1.74e-03 | 123 | 40 | 3 | GO:0001942 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.76e-03 | 1190 | 40 | 8 | GO:0008284 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.80e-03 | 1194 | 40 | 8 | GO:0000902 | |
| GeneOntologyBiologicalProcess | prostate gland epithelium morphogenesis | 1.86e-03 | 33 | 40 | 2 | GO:0060740 | |
| GeneOntologyBiologicalProcess | molting cycle process | 1.86e-03 | 126 | 40 | 3 | GO:0022404 | |
| GeneOntologyBiologicalProcess | hair cycle process | 1.86e-03 | 126 | 40 | 3 | GO:0022405 | |
| GeneOntologyBiologicalProcess | epidermis development | 1.88e-03 | 461 | 40 | 5 | GO:0008544 | |
| GeneOntologyBiologicalProcess | prostate gland morphogenesis | 1.98e-03 | 34 | 40 | 2 | GO:0060512 | |
| GeneOntologyBiologicalProcess | coronary vasculature morphogenesis | 1.98e-03 | 34 | 40 | 2 | GO:0060977 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 1.98e-03 | 34 | 40 | 2 | GO:1903055 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.08e-03 | 131 | 40 | 3 | GO:0030510 | |
| GeneOntologyBiologicalProcess | response to fibroblast growth factor | 2.13e-03 | 132 | 40 | 3 | GO:0071774 | |
| GeneOntologyBiologicalProcess | artery development | 2.18e-03 | 133 | 40 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | heart formation | 2.22e-03 | 36 | 40 | 2 | GO:0060914 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 2.22e-03 | 36 | 40 | 2 | GO:0033146 | |
| GeneOntologyBiologicalProcess | metanephric nephron development | 2.47e-03 | 38 | 40 | 2 | GO:0072210 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 2.72e-03 | 302 | 40 | 4 | GO:0001649 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 3.01e-03 | 42 | 40 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 3.03e-03 | 750 | 40 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | molting cycle | 3.06e-03 | 150 | 40 | 3 | GO:0042303 | |
| GeneOntologyBiologicalProcess | hair cycle | 3.06e-03 | 150 | 40 | 3 | GO:0042633 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 3.15e-03 | 43 | 40 | 2 | GO:0071711 | |
| GeneOntologyBiologicalProcess | digestive tract development | 3.17e-03 | 152 | 40 | 3 | GO:0048565 | |
| GeneOntologyCellularComponent | extracellular matrix | ADAMTS10 LAMA3 LAMA5 LAMB2 LAMB3 HTRA1 FCGBP ADAMTSL5 TNC TNXB MUC6 IGFBPL1 FBN3 OTOG | 8.55e-12 | 656 | 40 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | ADAMTS10 LAMA3 LAMA5 LAMB2 LAMB3 HTRA1 FCGBP ADAMTSL5 TNC TNXB MUC6 IGFBPL1 FBN3 OTOG | 8.91e-12 | 658 | 40 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 2.39e-09 | 10 | 40 | 4 | GO:0043256 | |
| GeneOntologyCellularComponent | laminin-5 complex | 2.59e-08 | 4 | 40 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | ADAMTS10 LAMA3 LAMA5 LAMB2 LAMB3 HTRA1 ADAMTSL5 TNC TNXB IGFBPL1 | 4.32e-08 | 530 | 40 | 10 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 1.83e-06 | 13 | 40 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 3.48e-06 | 122 | 40 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 4.33e-06 | 17 | 40 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-11 complex | 1.07e-05 | 3 | 40 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-3 complex | 1.07e-05 | 3 | 40 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | tenascin complex | 2.14e-05 | 4 | 40 | 2 | GO:0090733 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.96e-04 | 59 | 40 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 2.75e-04 | 13 | 40 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | phagocytic cup | 1.60e-03 | 31 | 40 | 2 | GO:0001891 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.82e-03 | 33 | 40 | 2 | GO:0043083 | |
| HumanPheno | Duplicated collecting system | 1.75e-06 | 24 | 20 | 4 | HP:0000081 | |
| HumanPheno | Abnormal renal collecting system morphology | 4.44e-06 | 30 | 20 | 4 | HP:0004742 | |
| HumanPheno | Scarring | 3.56e-05 | 102 | 20 | 5 | HP:0100699 | |
| HumanPheno | Recurrent subcortical infarcts | 8.75e-05 | 4 | 20 | 2 | HP:0007236 | |
| HumanPheno | Ureteral duplication | 1.13e-04 | 67 | 20 | 4 | HP:0000073 | |
| HumanPheno | Abdominal organ duplication | 1.27e-04 | 69 | 20 | 4 | HP:0005217 | |
| HumanPheno | Renal duplication | 1.27e-04 | 69 | 20 | 4 | HP:0000075 | |
| HumanPheno | Renal tubular epithelial necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0008682 | |
| HumanPheno | Renal necrosis | 1.45e-04 | 5 | 20 | 2 | HP:0032618 | |
| HumanPheno | Pyoderma | 1.45e-04 | 5 | 20 | 2 | HP:0000999 | |
| HumanPheno | Atypical scarring of skin | 1.67e-04 | 74 | 20 | 4 | HP:0000987 | |
| HumanPheno | Lacunar stroke | 2.18e-04 | 6 | 20 | 2 | HP:0032325 | |
| HumanPheno | Vascular granular osmiophilic material deposition | 3.04e-04 | 7 | 20 | 2 | HP:0003657 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 3.04e-04 | 7 | 20 | 2 | HP:0020117 | |
| HumanPheno | Atrophic scars | 3.69e-04 | 37 | 20 | 3 | HP:0001075 | |
| HumanPheno | High myopia | 4.20e-04 | 94 | 20 | 4 | HP:0011003 | |
| HumanPheno | Ureteral obstruction | 4.32e-04 | 39 | 20 | 3 | HP:0006000 | |
| HumanPheno | Aplasia cutis congenita | 5.02e-04 | 41 | 20 | 3 | HP:0001057 | |
| HumanPheno | Congenital localized absence of skin | 5.19e-04 | 9 | 20 | 2 | HP:0007383 | |
| HumanPheno | Mitten deformity | 5.19e-04 | 9 | 20 | 2 | HP:0004057 | |
| HumanPheno | Bilateral choanal atresia | 5.19e-04 | 9 | 20 | 2 | HP:0004502 | |
| HumanPheno | Abnormal dermatological laboratory findings | 6.47e-04 | 10 | 20 | 2 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 6.47e-04 | 10 | 20 | 2 | HP:0003341 | |
| HumanPheno | Abulia | 6.47e-04 | 10 | 20 | 2 | HP:0012671 | |
| HumanPheno | Right ventricular hypertrophy | 6.61e-04 | 45 | 20 | 3 | HP:0001667 | |
| HumanPheno | Alopecia of scalp | 6.61e-04 | 45 | 20 | 3 | HP:0002293 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 1.94e-06 | 12 | 30 | 3 | MP:0011159 | |
| MousePheno | hearing/vestibular/ear phenotype | 7.96e-05 | 905 | 30 | 9 | MP:0005377 | |
| MousePheno | impaired branching involved in ureteric bud morphogenesis | 9.00e-05 | 41 | 30 | 3 | MP:0004936 | |
| MousePheno | increased kidney apoptosis | 1.04e-04 | 43 | 30 | 3 | MP:0011368 | |
| MousePheno | abnormal renal tubule morphology | 1.11e-04 | 227 | 30 | 5 | MP:0002703 | |
| MousePheno | abnormal branching involved in ureteric bud morphogenesis | 1.19e-04 | 45 | 30 | 3 | MP:0010981 | |
| MousePheno | abnormal kidney apoptosis | 1.94e-04 | 53 | 30 | 3 | MP:0011367 | |
| MousePheno | abnormal ureteric bud morphology | 2.41e-04 | 57 | 30 | 3 | MP:0006032 | |
| MousePheno | cornea deposits | 3.99e-04 | 14 | 30 | 2 | MP:0005544 | |
| MousePheno | abnormal ear morphology | 4.18e-04 | 470 | 30 | 6 | MP:0002102 | |
| MousePheno | abnormal inner ear morphology | 4.23e-04 | 303 | 30 | 5 | MP:0000026 | |
| Domain | EGF-like_dom | LRP2 LAMA3 LAMA5 CLEC18C LAMB2 CLEC18A FAT4 FCGBP CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 OTOG PEAR1 STAB1 | 8.32e-24 | 249 | 40 | 18 | IPR000742 |
| Domain | EGF | LRP2 LAMA3 LAMA5 CLEC18C LAMB2 CLEC18A FAT4 FCGBP CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 PEAR1 STAB1 | 1.90e-22 | 235 | 40 | 17 | SM00181 |
| Domain | EGF_1 | LRP2 LAMA3 LAMA5 CLEC18C LAMB2 LAMB3 CLEC18A FAT4 CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 PEAR1 STAB1 | 7.80e-22 | 255 | 40 | 17 | PS00022 |
| Domain | EGF-like_CS | LRP2 LAMA3 LAMA5 CLEC18C LAMB2 LAMB3 CLEC18A FAT4 CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 PEAR1 STAB1 | 1.17e-21 | 261 | 40 | 17 | IPR013032 |
| Domain | EGF_2 | LRP2 LAMA3 LAMA5 CLEC18C LAMB2 LAMB3 CLEC18A FAT4 CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 PEAR1 STAB1 | 1.51e-21 | 265 | 40 | 17 | PS01186 |
| Domain | Growth_fac_rcpt_ | LRP2 LAMA3 LAMA5 LAMB2 FAT4 HTRA1 TNC TNXB IGFBPL1 FBN3 NOTCH1 NOTCH3 STAB1 | 5.74e-18 | 156 | 40 | 13 | IPR009030 |
| Domain | EGF_3 | LRP2 CLEC18C CLEC18A FAT4 CLEC18B TNC TNXB FBN3 MEGF10 NOTCH1 NOTCH3 OTOG PEAR1 STAB1 | 2.93e-17 | 235 | 40 | 14 | PS50026 |
| Domain | Laminin_EGF | 7.64e-13 | 35 | 40 | 7 | PF00053 | |
| Domain | EGF_Lam | 7.64e-13 | 35 | 40 | 7 | SM00180 | |
| Domain | Laminin_EGF | 1.43e-12 | 38 | 40 | 7 | IPR002049 | |
| Domain | EGF_extracell | 4.22e-11 | 60 | 40 | 7 | IPR013111 | |
| Domain | EGF_2 | 4.22e-11 | 60 | 40 | 7 | PF07974 | |
| Domain | hEGF | 3.30e-09 | 28 | 40 | 5 | PF12661 | |
| Domain | EGF_LAM_2 | 4.76e-09 | 30 | 40 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 4.76e-09 | 30 | 40 | 5 | PS01248 | |
| Domain | EGF | 8.33e-09 | 126 | 40 | 7 | PF00008 | |
| Domain | TIL_dom | 1.78e-08 | 14 | 40 | 4 | IPR002919 | |
| Domain | LAMININ_NTER | 3.22e-08 | 16 | 40 | 4 | PS51117 | |
| Domain | Laminin_N | 3.22e-08 | 16 | 40 | 4 | PF00055 | |
| Domain | Laminin_N | 3.22e-08 | 16 | 40 | 4 | IPR008211 | |
| Domain | LamNT | 3.22e-08 | 16 | 40 | 4 | SM00136 | |
| Domain | EGF_CA | 2.20e-07 | 122 | 40 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.42e-07 | 124 | 40 | 6 | IPR001881 | |
| Domain | EGF_CA | 1.07e-06 | 86 | 40 | 5 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.94e-06 | 97 | 40 | 5 | IPR018097 | |
| Domain | TIL | 1.98e-06 | 12 | 40 | 3 | PF01826 | |
| Domain | C8 | 1.98e-06 | 12 | 40 | 3 | PF08742 | |
| Domain | EGF_CA | 2.15e-06 | 99 | 40 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.26e-06 | 100 | 40 | 5 | PS00010 | |
| Domain | Unchr_dom_Cys-rich | 2.56e-06 | 13 | 40 | 3 | IPR014853 | |
| Domain | C8 | 2.56e-06 | 13 | 40 | 3 | SM00832 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.01e-06 | 106 | 40 | 5 | IPR000152 | |
| Domain | - | 4.07e-06 | 15 | 40 | 3 | 3.40.33.10 | |
| Domain | CAP | 4.07e-06 | 15 | 40 | 3 | PF00188 | |
| Domain | CAP_domain | 4.07e-06 | 15 | 40 | 3 | IPR014044 | |
| Domain | SCP | 4.07e-06 | 15 | 40 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 4.07e-06 | 15 | 40 | 3 | IPR001283 | |
| Domain | VWFD | 5.00e-06 | 16 | 40 | 3 | PS51233 | |
| Domain | VWD | 5.00e-06 | 16 | 40 | 3 | SM00216 | |
| Domain | VWF_type-D | 5.00e-06 | 16 | 40 | 3 | IPR001846 | |
| Domain | VWD | 5.00e-06 | 16 | 40 | 3 | PF00094 | |
| Domain | VWC_out | 8.61e-06 | 19 | 40 | 3 | SM00215 | |
| Domain | DUF3454 | 1.34e-05 | 3 | 40 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.34e-05 | 3 | 40 | 2 | IPR024600 | |
| Domain | DUF3454 | 1.34e-05 | 3 | 40 | 2 | SM01334 | |
| Domain | NOD | 2.68e-05 | 4 | 40 | 2 | PF06816 | |
| Domain | Notch | 2.68e-05 | 4 | 40 | 2 | IPR008297 | |
| Domain | NODP | 2.68e-05 | 4 | 40 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 2.68e-05 | 4 | 40 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.68e-05 | 4 | 40 | 2 | IPR010660 | |
| Domain | NOD | 2.68e-05 | 4 | 40 | 2 | SM01338 | |
| Domain | NODP | 2.68e-05 | 4 | 40 | 2 | SM01339 | |
| Domain | LNR | 4.45e-05 | 5 | 40 | 2 | PS50258 | |
| Domain | Laminin_aI | 4.45e-05 | 5 | 40 | 2 | IPR009254 | |
| Domain | Laminin_I | 4.45e-05 | 5 | 40 | 2 | PF06008 | |
| Domain | Laminin_II | 4.45e-05 | 5 | 40 | 2 | PF06009 | |
| Domain | Laminin_domII | 4.45e-05 | 5 | 40 | 2 | IPR010307 | |
| Domain | - | 5.41e-05 | 97 | 40 | 4 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 5.86e-05 | 99 | 40 | 4 | IPR016186 | |
| Domain | LAM_G_DOMAIN | 7.29e-05 | 38 | 40 | 3 | PS50025 | |
| Domain | CTDL_fold | 7.94e-05 | 107 | 40 | 4 | IPR016187 | |
| Domain | Laminin_G_2 | 8.51e-05 | 40 | 40 | 3 | PF02210 | |
| Domain | Notch_dom | 9.33e-05 | 7 | 40 | 2 | IPR000800 | |
| Domain | Notch | 9.33e-05 | 7 | 40 | 2 | PF00066 | |
| Domain | NL | 9.33e-05 | 7 | 40 | 2 | SM00004 | |
| Domain | VWF_dom | 9.86e-05 | 42 | 40 | 3 | IPR001007 | |
| Domain | C-type_lectin_CS | 1.06e-04 | 43 | 40 | 3 | IPR018378 | |
| Domain | LamG | 1.13e-04 | 44 | 40 | 3 | SM00282 | |
| Domain | LAMININ_IVA | 1.24e-04 | 8 | 40 | 2 | PS51115 | |
| Domain | Laminin_B | 1.24e-04 | 8 | 40 | 2 | PF00052 | |
| Domain | LamB | 1.24e-04 | 8 | 40 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.24e-04 | 8 | 40 | 2 | IPR000034 | |
| Domain | Laminin_G | 2.59e-04 | 58 | 40 | 3 | IPR001791 | |
| Domain | EMI_domain | 5.27e-04 | 16 | 40 | 2 | IPR011489 | |
| Domain | EMI | 5.96e-04 | 17 | 40 | 2 | PS51041 | |
| Domain | C_TYPE_LECTIN_1 | 6.67e-04 | 80 | 40 | 3 | PS00615 | |
| Domain | IB | 6.70e-04 | 18 | 40 | 2 | SM00121 | |
| Domain | Lectin_C | 7.69e-04 | 84 | 40 | 3 | PF00059 | |
| Domain | CLECT | 7.69e-04 | 84 | 40 | 3 | SM00034 | |
| Domain | C_TYPE_LECTIN_2 | 7.96e-04 | 85 | 40 | 3 | PS50041 | |
| Domain | C-type_lectin-like | 8.23e-04 | 86 | 40 | 3 | IPR001304 | |
| Domain | IGFBP_N_2 | 8.29e-04 | 20 | 40 | 2 | PS51323 | |
| Domain | IGFBP-like | 8.29e-04 | 20 | 40 | 2 | IPR000867 | |
| Domain | IGFBP | 8.29e-04 | 20 | 40 | 2 | PF00219 | |
| Domain | CT | 1.01e-03 | 22 | 40 | 2 | SM00041 | |
| Domain | Galactose-bd-like | 1.07e-03 | 94 | 40 | 3 | IPR008979 | |
| Domain | - | 1.10e-03 | 95 | 40 | 3 | 2.60.120.200 | |
| Domain | ADAM_spacer1 | 1.10e-03 | 23 | 40 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.10e-03 | 23 | 40 | 2 | PF05986 | |
| Domain | - | 1.20e-03 | 24 | 40 | 2 | 4.10.530.10 | |
| Domain | Fibrinogen_a/b/g_C_2 | 1.20e-03 | 24 | 40 | 2 | IPR014715 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.20e-03 | 24 | 40 | 2 | IPR013273 | |
| Domain | Cys_knot_C | 1.30e-03 | 25 | 40 | 2 | IPR006207 | |
| Domain | CTCK_2 | 1.30e-03 | 25 | 40 | 2 | PS01225 | |
| Domain | cEGF | 1.41e-03 | 26 | 40 | 2 | IPR026823 | |
| Domain | cEGF | 1.41e-03 | 26 | 40 | 2 | PF12662 | |
| Domain | Fibrinogen_C | 1.52e-03 | 27 | 40 | 2 | PF00147 | |
| Domain | FBG | 1.75e-03 | 29 | 40 | 2 | SM00186 | |
| Domain | - | 1.87e-03 | 30 | 40 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.87e-03 | 30 | 40 | 2 | IPR014716 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 3.49e-09 | 11 | 27 | 4 | M158 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.00e-08 | 84 | 27 | 6 | M7098 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.99e-08 | 300 | 27 | 8 | M610 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 8.13e-08 | 59 | 27 | 5 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.44e-07 | 66 | 27 | 5 | M18 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.67e-07 | 68 | 27 | 5 | M27303 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.83e-07 | 30 | 27 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.83e-07 | 30 | 27 | 4 | M27216 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.93e-07 | 76 | 27 | 5 | M27219 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 4.20e-07 | 33 | 27 | 4 | M39503 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.03e-06 | 41 | 27 | 4 | M27778 | |
| Pathway | WP_FOCAL_ADHESION | 1.18e-06 | 187 | 27 | 6 | MM15913 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.65e-06 | 46 | 27 | 4 | M239 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.70e-06 | 199 | 27 | 6 | M7253 | |
| Pathway | WP_FOCAL_ADHESION | 1.70e-06 | 199 | 27 | 6 | M39402 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.09e-06 | 140 | 27 | 5 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.75e-06 | 143 | 27 | 5 | M27275 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 7.09e-06 | 66 | 27 | 4 | MM15925 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.45e-05 | 79 | 27 | 4 | M27643 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.85e-05 | 84 | 27 | 4 | M3228 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.86e-05 | 302 | 27 | 6 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 2.87e-05 | 326 | 27 | 6 | MM15917 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 3.14e-05 | 96 | 27 | 4 | M39834 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 3.52e-05 | 5 | 27 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.52e-05 | 5 | 27 | 2 | MM14733 | |
| Pathway | WP_PI3KAKT_SIGNALING | 3.57e-05 | 339 | 27 | 6 | M39736 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 5.27e-05 | 6 | 27 | 2 | M27068 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 7.38e-05 | 7 | 27 | 2 | MM14734 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 9.89e-05 | 250 | 27 | 5 | M27554 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 1.90e-04 | 59 | 27 | 3 | M46460 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.92e-04 | 11 | 27 | 2 | M47865 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.92e-04 | 11 | 27 | 2 | M27372 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.30e-04 | 12 | 27 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.30e-04 | 12 | 27 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.72e-04 | 13 | 27 | 2 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.72e-04 | 13 | 27 | 2 | M47534 | |
| Pathway | WP_CANCER_PATHWAYS | 3.26e-04 | 507 | 27 | 6 | M48302 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.42e-04 | 72 | 27 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.56e-04 | 73 | 27 | 3 | MM15906 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.65e-04 | 15 | 27 | 2 | M27161 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 4.72e-04 | 17 | 27 | 2 | M39443 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 5.30e-04 | 18 | 27 | 2 | M614 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 8.72e-04 | 23 | 27 | 2 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 9.50e-04 | 24 | 27 | 2 | M11190 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.03e-03 | 25 | 27 | 2 | M27880 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.15e-03 | 109 | 27 | 3 | MM15164 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 1.20e-03 | 27 | 27 | 2 | M39545 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.21e-03 | 111 | 27 | 3 | M27416 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.29e-03 | 28 | 27 | 2 | M6177 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.31e-03 | 439 | 27 | 5 | M42563 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.49e-03 | 30 | 27 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 1.49e-03 | 30 | 27 | 2 | M39641 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.67e-03 | 124 | 27 | 3 | M27285 | |
| Pathway | PID_SYNDECAN_4_PATHWAY | 1.69e-03 | 32 | 27 | 2 | M165 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 1.91e-03 | 34 | 27 | 2 | M39390 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.26e-03 | 37 | 27 | 2 | M39506 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-03 | 39 | 27 | 2 | M27417 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.51e-03 | 39 | 27 | 2 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.51e-03 | 39 | 27 | 2 | MM15165 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.04e-03 | 43 | 27 | 2 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 3.04e-03 | 532 | 27 | 5 | M27870 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.20e-03 | 325 | 27 | 4 | M12868 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.32e-03 | 45 | 27 | 2 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.47e-03 | 46 | 27 | 2 | MM15971 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.62e-03 | 47 | 27 | 2 | MM14925 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.62e-03 | 47 | 27 | 2 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.93e-03 | 49 | 27 | 2 | M618 | |
| Pathway | PID_NOTCH_PATHWAY | 5.65e-03 | 59 | 27 | 2 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 6.03e-03 | 61 | 27 | 2 | M39540 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 6.03e-03 | 61 | 27 | 2 | M27103 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION | 6.42e-03 | 63 | 27 | 2 | M39366 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.07e-02 | 82 | 27 | 2 | MM15922 | |
| Pubmed | 3.13e-10 | 10 | 40 | 4 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 4.92e-10 | 11 | 40 | 4 | 21524702 | |
| Pubmed | 7.37e-10 | 12 | 40 | 4 | 9396756 | ||
| Pubmed | 8.46e-10 | 167 | 40 | 7 | 22159717 | ||
| Pubmed | 9.92e-10 | 40 | 40 | 5 | 27068110 | ||
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 1.41e-09 | 3 | 40 | 3 | 26170455 | |
| Pubmed | 1.41e-09 | 3 | 40 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 1.41e-09 | 3 | 40 | 3 | 33603190 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.03e-09 | 15 | 40 | 4 | 15895400 | |
| Pubmed | 2.70e-09 | 16 | 40 | 4 | 17601529 | ||
| Pubmed | 4.54e-09 | 18 | 40 | 4 | 11311202 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 10651091 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 16709836 | ||
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 8081888 | ||
| Pubmed | 7.17e-09 | 20 | 40 | 4 | 22911573 | ||
| Pubmed | 1.68e-08 | 146 | 40 | 6 | 27068509 | ||
| Pubmed | 2.20e-08 | 26 | 40 | 4 | 24742657 | ||
| Pubmed | 3.49e-08 | 29 | 40 | 4 | 22613833 | ||
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 4.92e-08 | 7 | 40 | 3 | 9004048 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 7.86e-08 | 8 | 40 | 3 | 9489770 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 7.86e-08 | 8 | 40 | 3 | 23529140 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.13e-07 | 101 | 40 | 5 | 20551380 | |
| Pubmed | 1.46e-07 | 210 | 40 | 6 | 16537572 | ||
| Pubmed | Beta4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. | 2.31e-07 | 11 | 40 | 3 | 8707838 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 2.31e-07 | 11 | 40 | 3 | 23472759 | |
| Pubmed | 6.35e-07 | 15 | 40 | 3 | 9264260 | ||
| Pubmed | 8.97e-07 | 153 | 40 | 5 | 25037231 | ||
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 1.14e-06 | 18 | 40 | 3 | 23041440 | |
| Pubmed | 1.26e-06 | 164 | 40 | 5 | 32409323 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9321695 | ||
| Pubmed | Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature. | 1.29e-06 | 2 | 40 | 2 | 34878922 | |
| Pubmed | Homozygosity mapping of a Weill-Marchesani syndrome locus to chromosome 19p13.3-p13.2. | 1.29e-06 | 2 | 40 | 2 | 11941487 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 12382139 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 8856503 | ||
| Pubmed | Biological function of laminin-5 and pathogenic impact of its deficiency. | 1.29e-06 | 2 | 40 | 2 | 17000025 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26634853 | ||
| Pubmed | Structural requirement for cell adhesion to kalinin (laminin-5). | 1.29e-06 | 2 | 40 | 2 | 7775432 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 21191019 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30859180 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17881497 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 29023469 | ||
| Pubmed | Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. | 1.29e-06 | 2 | 40 | 2 | 12359049 | |
| Pubmed | Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). | 1.29e-06 | 2 | 40 | 2 | 9492085 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24728738 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17202312 | ||
| Pubmed | Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis. | 1.29e-06 | 2 | 40 | 2 | 33021719 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 26563570 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14595837 | ||
| Pubmed | Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis. | 1.29e-06 | 2 | 40 | 2 | 21768299 | |
| Pubmed | The change in tenascin expression in mouse uterus during early pregnancy. | 1.29e-06 | 2 | 40 | 2 | 9013311 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 25700162 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15455729 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9205497 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 7509489 | ||
| Pubmed | The effects of tenascin C knockdown on trabecular meshwork outflow resistance. | 1.29e-06 | 2 | 40 | 2 | 23882691 | |
| Pubmed | Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. | 1.29e-06 | 2 | 40 | 2 | 18069660 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 16507912 | ||
| Pubmed | A Wnt/Notch/Pax7 signaling network supports tissue integrity in tongue development. | 1.35e-06 | 19 | 40 | 3 | 28438836 | |
| Pubmed | 1.74e-06 | 175 | 40 | 5 | 28071719 | ||
| Pubmed | 1.85e-06 | 21 | 40 | 3 | 27856617 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.12e-06 | 79 | 40 | 4 | 18757743 | |
| Pubmed | 2.34e-06 | 81 | 40 | 4 | 39217171 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 2.80e-06 | 24 | 40 | 3 | 26116661 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.18e-06 | 560 | 40 | 7 | 21653829 | |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 3.60e-06 | 26 | 40 | 3 | 34189436 | |
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 3.87e-06 | 3 | 40 | 2 | 7687262 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15987768 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 8012114 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7530141 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7615640 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 3.87e-06 | 3 | 40 | 2 | 25846406 | |
| Pubmed | Globular domains 4/5 of the laminin alpha3 chain mediate deposition of precursor laminin 5. | 3.87e-06 | 3 | 40 | 2 | 15316072 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7918097 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 8645602 | ||
| Pubmed | Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. | 3.87e-06 | 3 | 40 | 2 | 31346528 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 27566587 | ||
| Pubmed | PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. | 3.87e-06 | 3 | 40 | 2 | 34846251 | |
| Pubmed | Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. | 3.87e-06 | 3 | 40 | 2 | 7694605 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 9019243 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 3.87e-06 | 3 | 40 | 2 | 17482449 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 3.87e-06 | 3 | 40 | 2 | 21471519 | |
| Pubmed | Smooth muscle Notch1 mediates neointimal formation after vascular injury. | 3.87e-06 | 3 | 40 | 2 | 19433762 | |
| Pubmed | Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions. | 3.87e-06 | 3 | 40 | 2 | 28498977 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15373767 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 27697639 | ||
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 3.87e-06 | 3 | 40 | 2 | 8833897 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 20801121 | ||
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 3.87e-06 | 3 | 40 | 2 | 18603785 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 18483410 | ||
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 3.87e-06 | 3 | 40 | 2 | 16165127 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 33179081 | ||
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 3.87e-06 | 3 | 40 | 2 | 15149852 | |
| Pubmed | KCTD10 regulates brown adipose tissue thermogenesis and metabolic function via Notch signaling. | 3.87e-06 | 3 | 40 | 2 | 34854382 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 37209968 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 3.87e-06 | 3 | 40 | 2 | 29767458 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 8113417 | ||
| Pubmed | The dynamic expression of tenascin-C and tenascin-X during early heart development in the mouse. | 3.87e-06 | 3 | 40 | 2 | 12823230 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7698746 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10481268 | ||
| Interaction | IGFL3 interactions | 6.41e-09 | 75 | 39 | 6 | int:IGFL3 | |
| Interaction | NTN5 interactions | 1.24e-07 | 24 | 39 | 4 | int:NTN5 | |
| Interaction | ELSPBP1 interactions | 9.05e-07 | 92 | 39 | 5 | int:ELSPBP1 | |
| Interaction | EDN3 interactions | 2.01e-06 | 108 | 39 | 5 | int:EDN3 | |
| Interaction | FBXO2 interactions | 1.22e-05 | 411 | 39 | 7 | int:FBXO2 | |
| Interaction | PRG2 interactions | 1.67e-05 | 285 | 39 | 6 | int:PRG2 | |
| Interaction | SIRPD interactions | 2.27e-05 | 86 | 39 | 4 | int:SIRPD | |
| Interaction | DEFA1 interactions | 4.11e-05 | 100 | 39 | 4 | int:DEFA1 | |
| Interaction | DLK2 interactions | 4.58e-05 | 36 | 39 | 3 | int:DLK2 | |
| Interaction | CEACAM8 interactions | 8.10e-05 | 119 | 39 | 4 | int:CEACAM8 | |
| Interaction | CFC1 interactions | 1.01e-04 | 126 | 39 | 4 | int:CFC1 | |
| Interaction | SLURP1 interactions | 1.69e-04 | 144 | 39 | 4 | int:SLURP1 | |
| Interaction | NXPH3 interactions | 1.92e-04 | 58 | 39 | 3 | int:NXPH3 | |
| Interaction | GML interactions | 1.92e-04 | 58 | 39 | 3 | int:GML | |
| Interaction | ALKAL2 interactions | 1.99e-04 | 11 | 39 | 2 | int:ALKAL2 | |
| Interaction | MANEA interactions | 2.12e-04 | 60 | 39 | 3 | int:MANEA | |
| Interaction | SPINK4 interactions | 2.38e-04 | 12 | 39 | 2 | int:SPINK4 | |
| Interaction | C1orf54 interactions | 2.98e-04 | 167 | 39 | 4 | int:C1orf54 | |
| Interaction | IGSF5 interactions | 3.27e-04 | 14 | 39 | 2 | int:IGSF5 | |
| Interaction | TG interactions | 3.27e-04 | 14 | 39 | 2 | int:TG | |
| Interaction | MARCHF1 interactions | 3.35e-04 | 70 | 39 | 3 | int:MARCHF1 | |
| Interaction | LGALS1 interactions | 4.28e-04 | 332 | 39 | 5 | int:LGALS1 | |
| Interaction | MBD1 interactions | 4.44e-04 | 77 | 39 | 3 | int:MBD1 | |
| Interaction | EGFL7 interactions | 4.44e-04 | 77 | 39 | 3 | int:EGFL7 | |
| Interaction | CST9L interactions | 4.61e-04 | 78 | 39 | 3 | int:CST9L | |
| Interaction | MAML2 interactions | 4.87e-04 | 17 | 39 | 2 | int:MAML2 | |
| Interaction | PI15 interactions | 5.53e-04 | 83 | 39 | 3 | int:PI15 | |
| Interaction | CALCA interactions | 6.11e-04 | 19 | 39 | 2 | int:CALCA | |
| Interaction | NID2 interactions | 6.14e-04 | 86 | 39 | 3 | int:NID2 | |
| Interaction | MAML3 interactions | 6.78e-04 | 20 | 39 | 2 | int:MAML3 | |
| Interaction | DEFB125 interactions | 6.78e-04 | 20 | 39 | 2 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 6.78e-04 | 20 | 39 | 2 | int:ZNF224 | |
| Cytoband | 16q22.1 | 4.18e-03 | 110 | 40 | 2 | 16q22.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.02e-03 | 797 | 40 | 4 | chr19p13 | |
| GeneFamily | Laminin subunits | 3.96e-09 | 12 | 32 | 4 | 626 | |
| GeneFamily | C-type lectin domain family | 7.75e-05 | 47 | 32 | 3 | 494 | |
| GeneFamily | Low density lipoprotein receptors | 2.34e-04 | 13 | 32 | 2 | 634 | |
| GeneFamily | Fibrinogen C domain containing | 8.88e-04 | 25 | 32 | 2 | 554 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.04e-03 | 27 | 32 | 2 | 1253 | |
| GeneFamily | PHD finger proteins | 1.10e-02 | 90 | 32 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | ADAMTS10 LAMA3 LAMA5 CLEC18C LAMB2 LAMB3 CLEC18A HTRA1 CLEC18B ADAMTSL5 TNC TNXB MUC6 IGFBPL1 FBN3 MEGF10 OTOG | 3.96e-14 | 1026 | 40 | 17 | M5889 |
| Coexpression | NABA_MATRISOME | ADAMTS10 LAMA3 LAMA5 CLEC18C LAMB2 LAMB3 CLEC18A HTRA1 CLEC18B ADAMTSL5 TNC TNXB MUC6 IGFBPL1 MEGF10 OTOG | 5.37e-13 | 1008 | 40 | 16 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.36e-11 | 196 | 40 | 9 | M3008 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 9.74e-11 | 20 | 40 | 5 | MM17053 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.11e-10 | 23 | 40 | 5 | M48001 | |
| Coexpression | NABA_CORE_MATRISOME | 2.78e-10 | 275 | 40 | 9 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.32e-10 | 191 | 40 | 8 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 6.61e-09 | 270 | 40 | 8 | MM17057 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.08e-07 | 40 | 40 | 4 | M5887 | |
| Coexpression | GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN | 1.18e-05 | 196 | 40 | 5 | M6174 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.32e-05 | 738 | 40 | 8 | MM17058 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | 1.34e-05 | 740 | 40 | 8 | M41202 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | 1.49e-05 | 751 | 40 | 8 | M5885 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 5.33e-05 | 135 | 40 | 4 | M5825 | |
| Coexpression | NABA_ECM_AFFILIATED | 9.81e-05 | 158 | 40 | 4 | MM17063 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.10e-04 | 313 | 40 | 5 | M40228 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.30e-04 | 170 | 40 | 4 | M5880 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MELANOCYTES | 1.41e-04 | 66 | 40 | 3 | MM3664 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.54e-04 | 68 | 40 | 3 | M1406 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN | 1.66e-04 | 181 | 40 | 4 | M40912 | |
| Coexpression | JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 2.06e-04 | 75 | 40 | 3 | MM1143 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS | 2.23e-04 | 77 | 40 | 3 | M40001 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_MAC_DN | 2.33e-04 | 198 | 40 | 4 | M5163 | |
| Coexpression | GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN | 2.38e-04 | 199 | 40 | 4 | M5264 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.69e-04 | 16 | 40 | 2 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.69e-04 | 16 | 40 | 2 | MM1296 | |
| Coexpression | LEE_LIVER_CANCER_HEPATOBLAST | 2.69e-04 | 16 | 40 | 2 | M13123 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 2.71e-04 | 206 | 40 | 4 | M14134 | |
| Coexpression | DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS | 4.08e-04 | 645 | 40 | 6 | M40158 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 4.86e-04 | 432 | 40 | 5 | MM419 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 8.46e-07 | 281 | 40 | 7 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 8.46e-07 | 281 | 40 | 7 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.46e-05 | 433 | 40 | 7 | Arv_EB-LF_1000_K4 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 2.71e-05 | 189 | 40 | 5 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_100 | 3.43e-05 | 98 | 40 | 4 | PCBC_ECTO_blastocyst_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_500 | 3.43e-05 | 495 | 40 | 7 | PCBC_ECTO_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 3.52e-05 | 497 | 40 | 7 | PCBC_ECTO_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_100 | 3.57e-05 | 99 | 40 | 4 | PCBC_ECTO_100 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_100 | 3.72e-05 | 100 | 40 | 4 | PCBC_ratio_ECTO_vs_SC_100 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | 6.92e-05 | 981 | 40 | 9 | Arv_EB-LF_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | LRP2 CLEC18C CLEC18A SHISA2 CLEC18B ZNF366 TNXB IGFBPL1 FBN3 | 7.49e-05 | 991 | 40 | 9 | PCBC_ECTO_fibroblast_1000 |
| CoexpressionAtlas | thyroid gland | 8.43e-05 | 240 | 40 | 5 | thyroid gland | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.89e-04 | 453 | 40 | 6 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 2.20e-04 | 466 | 40 | 6 | GSM777050_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.79e-04 | 487 | 40 | 6 | PCBC_ECTO_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 3.08e-04 | 496 | 40 | 6 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_200 | 3.10e-04 | 14 | 40 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k5 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 3.52e-04 | 73 | 40 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 3.52e-04 | 73 | 40 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | 4.17e-04 | 1245 | 40 | 9 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-reprogram_NA_vs_Ectoderm Differentiated Cells-reprogram_OSKM - NLT-Confounder_removed-fold2.0_adjp0.05 | 4.27e-04 | 78 | 40 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-OSKM - NLT_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_top-relative-expression-ranked_1000 | 4.41e-04 | 990 | 40 | 8 | PCBC_ECTO_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | 4.47e-04 | 992 | 40 | 8 | PCBC_EB_blastocyst_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 4.53e-04 | 994 | 40 | 8 | PCBC_EB_1000 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 4.54e-04 | 345 | 40 | 5 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.72e-04 | 348 | 40 | 5 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.50e-04 | 85 | 40 | 3 | GSM777067_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_induced-Ectoderm_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_100 | 8.57e-04 | 99 | 40 | 3 | PCBC_ECTO_fibroblast_100 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.55e-07 | 172 | 40 | 5 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.69e-07 | 180 | 40 | 5 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.87e-07 | 187 | 40 | 5 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 7.83e-07 | 192 | 40 | 5 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 193 | 40 | 5 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 193 | 40 | 5 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.03e-07 | 193 | 40 | 5 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.24e-07 | 194 | 40 | 5 | c992e3357f4bf3069f8d697803e5785e49a2ef0a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 8.89e-07 | 197 | 40 | 5 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 8.89e-07 | 197 | 40 | 5 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.34e-07 | 199 | 40 | 5 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 9.57e-07 | 200 | 40 | 5 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor-Noncycling_AT2_Precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.12e-05 | 155 | 40 | 4 | 9cad73d0b8ead289e1073d1a2e00bbeb1228308c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 158 | 40 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 158 | 40 | 4 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 158 | 40 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.27e-05 | 160 | 40 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 1.31e-05 | 161 | 40 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.44e-05 | 165 | 40 | 4 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 166 | 40 | 4 | fcd0bd70b553789092249806ace324b77bd10481 | |
| ToppCell | wk_20-22-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 166 | 40 | 4 | b60954e5625743657d0fd9264b738b46e72fd8a6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-05 | 171 | 40 | 4 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.65e-05 | 171 | 40 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.89e-05 | 177 | 40 | 4 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | 21-Trachea-Epithelial-Submucosal_gland|Trachea / Age, Tissue, Lineage and Cell class | 1.94e-05 | 178 | 40 | 4 | 3e406e38eea0d38dc25edecf703c4c89ec6a28e0 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.98e-05 | 179 | 40 | 4 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 180 | 40 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.02e-05 | 180 | 40 | 4 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 180 | 40 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-05 | 182 | 40 | 4 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.16e-05 | 183 | 40 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.16e-05 | 183 | 40 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.16e-05 | 183 | 40 | 4 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.16e-05 | 183 | 40 | 4 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.16e-05 | 183 | 40 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 184 | 40 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 184 | 40 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 184 | 40 | 4 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 184 | 40 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 184 | 40 | 4 | c9d7ec17cc5b7ba1b1e721ca392746e8f4a3d41f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 184 | 40 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 184 | 40 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-05 | 184 | 40 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 185 | 40 | 4 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.25e-05 | 185 | 40 | 4 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | e502ec54971f518d0cf1b619b745607a8ab5ddf3 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-05 | 185 | 40 | 4 | cefd81adb480c027545a5c78dcd05669783717f4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.30e-05 | 186 | 40 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 188 | 40 | 4 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.40e-05 | 188 | 40 | 4 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.40e-05 | 188 | 40 | 4 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.40e-05 | 188 | 40 | 4 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.45e-05 | 189 | 40 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.45e-05 | 189 | 40 | 4 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.45e-05 | 189 | 40 | 4 | 2d32f09efa982ae458568f6b1cd06bb5078d42a3 | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-05 | 189 | 40 | 4 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.50e-05 | 190 | 40 | 4 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.50e-05 | 190 | 40 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-05 | 190 | 40 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-05 | 190 | 40 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-05 | 190 | 40 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 190 | 40 | 4 | c1bfc1960a3df49c0f459454a7363804c32418ee | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.55e-05 | 191 | 40 | 4 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.55e-05 | 191 | 40 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.55e-05 | 191 | 40 | 4 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-05 | 192 | 40 | 4 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-05 | 192 | 40 | 4 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-05 | 192 | 40 | 4 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-early_osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-05 | 193 | 40 | 4 | 5e46a9f65e85aca78f825fdef88a95b97eec8743 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 194 | 40 | 4 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 194 | 40 | 4 | 7bf6edefd13047e04665dbe34051ef3f481f85a4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-05 | 194 | 40 | 4 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | 18-Airway-Epithelial-Bud_tip_adjacent|Airway / Age, Tissue, Lineage and Cell class | 2.71e-05 | 194 | 40 | 4 | b45f1e80074a19245bc5dc4b3a583419a1904404 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-05 | 194 | 40 | 4 | 19e5beae2c1f8bf42cbe618e89810ce7b01a396c | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.71e-05 | 194 | 40 | 4 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 194 | 40 | 4 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.77e-05 | 195 | 40 | 4 | 9a9e074f7ac04656dccbed2f0df11377e33d3c05 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-05 | 195 | 40 | 4 | fdbb4abc0c79a6aeace71bfa5a5c5576ca39d758 | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.77e-05 | 195 | 40 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 195 | 40 | 4 | 45d1acd316d0ced97dfb150c3a943128d8fa4e7e | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.77e-05 | 195 | 40 | 4 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-05 | 195 | 40 | 4 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 196 | 40 | 4 | cd507ee2baf4f52d6498811b3510d3164b56311f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 196 | 40 | 4 | 55a10faafcbe075eefdfcd7cff25ded040c23538 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Macroglial|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.82e-05 | 196 | 40 | 4 | 8025ec8aee8455c7b0261aa4a0caacebd2f50634 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.82e-05 | 196 | 40 | 4 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.82e-05 | 196 | 40 | 4 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-05 | 196 | 40 | 4 | 73f029d2b276776d6c24356b14c6592c9cb74bd5 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.82e-05 | 196 | 40 | 4 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 196 | 40 | 4 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.82e-05 | 196 | 40 | 4 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 197 | 40 | 4 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.88e-05 | 197 | 40 | 4 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| Computational | Adhesion molecules. | 6.61e-07 | 141 | 25 | 6 | MODULE_122 | |
| Computational | Trachea genes. | 3.19e-05 | 415 | 25 | 7 | MODULE_6 | |
| Computational | DRG (dorsal root ganglia) genes. | 1.99e-04 | 384 | 25 | 6 | MODULE_2 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-04 | 50 | 25 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2 | |
| Computational | Lung genes. | 3.85e-04 | 434 | 25 | 6 | MODULE_5 | |
| Computational | Intermediate filaments and MT. | 5.04e-04 | 68 | 25 | 3 | MODULE_438 | |
| Computational | Placenta genes. | 5.44e-04 | 463 | 25 | 6 | MODULE_38 | |
| Computational | Ovary genes. | 1.38e-03 | 368 | 25 | 5 | MODULE_1 | |
| Computational | Neighborhood of CDH3 | 1.76e-03 | 27 | 25 | 2 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 1.89e-03 | 28 | 25 | 2 | GNF2_SERPINB5 | |
| Computational | Genes in the cancer module 153. | 2.78e-03 | 34 | 25 | 2 | MODULE_153 | |
| Drug | AC1L9INI | 7.12e-10 | 59 | 39 | 6 | CID000445839 | |
| Drug | kalinin | 3.69e-08 | 55 | 39 | 5 | CID000032518 | |
| Drug | pyrachlostrobin | LRP2 LAMA5 LAMB2 HTRA1 TNC IGFBPL1 MEGF10 NOTCH1 NOTCH3 LPP STAB1 | 7.37e-08 | 811 | 39 | 11 | ctd:C513428 |
| Drug | Sikvav | 7.62e-08 | 24 | 39 | 4 | CID005487517 | |
| Drug | Rgd Peptide | 1.49e-07 | 239 | 39 | 7 | CID000104802 | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 1.90e-07 | 373 | 39 | 8 | ctd:C540355 | |
| Drug | BM165 | 7.59e-07 | 11 | 39 | 3 | CID003352881 | |
| Drug | AC1L1G72 | 7.59e-07 | 11 | 39 | 3 | CID000003553 | |
| Drug | Gdrgdsp | 1.16e-06 | 109 | 39 | 5 | CID000115346 | |
| Drug | ALT-711 | 6.05e-06 | 21 | 39 | 3 | CID000216304 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.55e-06 | 155 | 39 | 5 | 6817_DN | |
| Drug | AC1L1B58 | 1.65e-05 | 29 | 39 | 3 | CID000001288 | |
| Drug | 3-ethylpyridine | 1.71e-05 | 4 | 39 | 2 | CID000010823 | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.14e-05 | 198 | 39 | 5 | 5984_UP | |
| Drug | dermatan sulfate | 3.55e-05 | 220 | 39 | 5 | CID000032756 | |
| Drug | Calcort | 3.76e-05 | 38 | 39 | 3 | CID000026709 | |
| Drug | Ikvav | 3.76e-05 | 38 | 39 | 3 | CID000131343 | |
| Drug | AC1O5SNJ | 4.27e-05 | 6 | 39 | 2 | CID006439900 | |
| Drug | B-Ms | 4.28e-05 | 114 | 39 | 4 | CID000445091 | |
| Drug | quinaprilat | 5.47e-05 | 43 | 39 | 3 | CID000107994 | |
| Drug | chondroitin sulfate | 6.75e-05 | 413 | 39 | 6 | CID000024766 | |
| Drug | hyaluronan | 8.27e-05 | 263 | 39 | 5 | CID000024759 | |
| Drug | 2,4-diaminopyrimidine | 1.08e-04 | 54 | 39 | 3 | CID000067431 | |
| Drug | LMWH | 1.18e-04 | 663 | 39 | 7 | CID000000772 | |
| Drug | CC270 | 1.41e-04 | 59 | 39 | 3 | CID006918852 | |
| Drug | LG 5 | 1.49e-04 | 60 | 39 | 3 | CID011840957 | |
| Drug | Bouin's solution | 1.64e-04 | 62 | 39 | 3 | CID000124013 | |
| Drug | Triton X-100 | 1.97e-04 | 66 | 39 | 3 | CID000005590 | |
| Drug | dysprosium | 2.77e-04 | 74 | 39 | 3 | CID000023912 | |
| Drug | A0395 | 2.88e-04 | 75 | 39 | 3 | CID009906466 | |
| Drug | fludrocortisone | 3.00e-04 | 76 | 39 | 3 | CID000031378 | |
| Drug | 2-amino-5-methylpyridine | 3.11e-04 | 77 | 39 | 3 | CID000015348 | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 3.14e-04 | 191 | 39 | 4 | 7538_UP | |
| Drug | YIGSR | 3.36e-04 | 79 | 39 | 3 | CID000123977 | |
| Drug | Denatonium benzoate [3734-33-6]; Down 200; 9uM; PC3; HT_HG-U133A | 3.46e-04 | 196 | 39 | 4 | 5061_DN | |
| Drug | Mustard Gas | 3.52e-04 | 1341 | 39 | 9 | ctd:D009151 | |
| Drug | nifedipine; Up 200; 10uM; MCF7; HG-U133A | 3.53e-04 | 197 | 39 | 4 | 335_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.60e-04 | 198 | 39 | 4 | 1061_DN | |
| Drug | Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.60e-04 | 198 | 39 | 4 | 4158_UP | |
| Drug | rapamycin; Up 200; 0.1uM; HL60; HG-U133A | 3.67e-04 | 199 | 39 | 4 | 362_UP | |
| Drug | AC1NQAN2 | 3.83e-04 | 17 | 39 | 2 | CID005193003 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.88e-04 | 83 | 39 | 3 | CID011968896 | |
| Drug | Grgds | 3.88e-04 | 83 | 39 | 3 | CID000123811 | |
| Drug | NSC 714187 | 4.16e-04 | 85 | 39 | 3 | CID005288693 | |
| Drug | glutamol-AMP | 4.30e-04 | 18 | 39 | 2 | CID005288456 | |
| Drug | 1,2-dimethylhydrazine | 4.31e-04 | 86 | 39 | 3 | CID000001322 | |
| Disease | Squamous cell carcinoma of esophagus | 1.64e-07 | 95 | 39 | 5 | C0279626 | |
| Disease | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | 1.70e-06 | 2 | 39 | 2 | cv:C0751587 | |
| Disease | CADASIL Syndrome | 1.70e-06 | 2 | 39 | 2 | C0751587 | |
| Disease | CADASILM | 1.70e-06 | 2 | 39 | 2 | C1449626 | |
| Disease | Junctional epidermolysis bullosa | 5.10e-06 | 3 | 39 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 5.10e-06 | 3 | 39 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 5.10e-06 | 3 | 39 | 2 | 226700 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.83e-06 | 28 | 39 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Epidermolysis Bullosa Progressiva | 1.02e-05 | 4 | 39 | 2 | C0079297 | |
| Disease | Herlitz Disease | 1.02e-05 | 4 | 39 | 2 | C0079683 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.70e-05 | 5 | 39 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.70e-05 | 5 | 39 | 2 | C2608084 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.70e-05 | 5 | 39 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | Junctional Epidermolysis Bullosa | 2.54e-05 | 6 | 39 | 2 | C0079301 | |
| Disease | vital capacity | 2.62e-05 | 1236 | 39 | 9 | EFO_0004312 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 3.56e-05 | 7 | 39 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 3.56e-05 | 7 | 39 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 3.56e-05 | 7 | 39 | 2 | C0399367 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 3.56e-05 | 7 | 39 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | tenascin measurement | 7.61e-05 | 10 | 39 | 2 | EFO_0008296 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.11e-04 | 12 | 39 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | Connective Tissue Diseases | 1.32e-04 | 13 | 39 | 2 | C0009782 | |
| Disease | Impaired cognition | 1.53e-04 | 14 | 39 | 2 | C0338656 | |
| Disease | Hodgkins lymphoma | 1.76e-04 | 82 | 39 | 3 | EFO_0000183 | |
| Disease | Dementia | 2.29e-04 | 17 | 39 | 2 | C0497327 | |
| Disease | Carcinoma, Pancreatic Ductal | 4.61e-04 | 24 | 39 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 5.42e-04 | 26 | 39 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 7.23e-04 | 30 | 39 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 8.23e-04 | 32 | 39 | 2 | DOID:10155 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CSCPDGFTGRACERD | 3886 | Q6V0I7 | |
| SEAVTRAECCCGGGR | 2316 | Q75N90 | |
| REDKCRVCGGDGSAC | 691 | Q9H324 | |
| CRGDARFVCKADSCG | 256 | Q9NQX1 | |
| SGACLCEAGFAGERC | 336 | Q96KG7 | |
| CEAGFAGERCEARLC | 341 | Q96KG7 | |
| VRDACGCDSGGDCEC | 1086 | Q6W4X9 | |
| CDCLPGFRGTFCEED | 931 | P46531 | |
| AGCEGCNCSRRGTIE | 1351 | Q16787 | |
| CEHGFTGDRCTDRLC | 336 | Q5VY43 | |
| DCFRIGDESRCFCGH | 261 | A6H8Z2 | |
| CRCAEGFEGTLCDRN | 531 | Q9UM47 | |
| DECGCCARCLGAEGA | 61 | Q8WX77 | |
| CYRCEDCGGLLSEGD | 566 | Q93052 | |
| ERRCDGLQDCGDGSD | 231 | O75074 | |
| CRAGFGGRTCSECQE | 1116 | P55268 | |
| APCSCDGDRRVDCSG | 31 | Q9BXB1 | |
| CGDGSDEAGCLFRDC | 2766 | P98164 | |
| CDRCQEGHFGFDGCG | 2051 | O15230 | |
| LEDRCGRCGGANDSC | 186 | Q6ZMM2 | |
| EHCEGGRARDACGCC | 51 | Q92743 | |
| GRARDACGCCEVCGA | 56 | Q92743 | |
| EGCESACREGCVCDA | 2361 | Q9Y6R7 | |
| GCDSLCRCREGGEVS | 3611 | Q9Y6R7 | |
| ESACREGCVCDAGFV | 4766 | Q9Y6R7 | |
| GCTTRCFEGCECDDR | 5146 | Q9Y6R7 | |
| DVATGCRACDCDFRG | 526 | Q13751 | |
| CRACDCDFRGTEGPG | 531 | Q13751 | |
| CGVDGGDDLSRDECV | 806 | Q6ZRI0 | |
| GADCGWDRGEVCRVC | 306 | Q9BUB5 | |
| AREGDCCSRRCGAQD | 6 | Q96GX9 | |
| GDRFYEFECCVCRGG | 226 | O43189 | |
| AERGGTCLFLGEECC | 391 | Q9UQF0 | |
| CRLCRGDSSGEGVCD | 186 | P08582 | |
| ERFDGGDATICCGSC | 56 | Q6UWI4 | |
| GRFREEECSCVCDIG | 271 | A5D8T8 | |
| GRFREEECSCVCDIG | 271 | Q6UXF7 | |
| GRFREEECSCVCDIG | 271 | Q8NCF0 | |
| VCFGGHLSCEFRECG | 96 | Q96MF0 | |
| GSCTQDRCFRCGEEG | 346 | Q9NUD5 | |
| DCRGRGRCEDGECIC | 376 | P22105 | |
| RGQCLDGRCVCEDGY | 566 | P22105 | |
| DGRCVCEDGYSGEDC | 571 | P22105 | |
| GDCRGRGECHDGSCV | 721 | P22105 | |
| RGRCVENECVCDEGF | 291 | P24821 | |
| DRGRCINGTCYCEEG | 321 | P24821 | |
| RCVDGRCECDDGFTG | 386 | P24821 | |
| RCECDDGFTGADCGE | 391 | P24821 | |
| EGVARCRCLDGFEGD | 841 | Q9NY15 | |
| CRCLDGFEGDGFSCT | 846 | Q9NY15 | |
| CECSLGYEGDGRVCT | 2076 | Q9NY15 | |
| EGGQERDCAGRDECL | 686 | Q8N895 | |
| DGSALRCGECGRCFT | 506 | Q6NUN9 | |
| CERRCDADPCCTGFG | 1996 | P01266 | |
| RCCFCHEEGDGATDG | 5031 | O14686 |